|
1
|
Sarwar S, Mulla M, Mulla M, Tanveer R,
Sabir M, Sultan A and Malik SA: Human papillomavirus, tobacco, and
poor oral hygiene can act synergetically, modulate the expression
of the nuclear factor kappa B signaling pathway for the development
and progression of head and neck cancer in the Pakistani
population. Chin Med J (Engl). 135:1829–1836. 2022.PubMed/NCBI View Article : Google Scholar
|
|
2
|
D'cruz A, Lin T, Anand AK, Atmakusuma D,
Calaguas MJ, Chitapanarux I, Cho BC, Goh BC, Guo Y, Hsieh WS, et
al: Consensus recommendations for management of head and neck
cancer in Asian countries: A review of international guidelines.
Oral Oncol. 49:872–877. 2013.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Kobayashi K, Hisamatsu K, Suzui N, Hara A,
Tomita H and Miyazaki T: A review of HPV-related head and neck
cancer. J Clin Med. 7(241)2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Leemans CR, Braakhuis BJ and Brakenhoff
RH: Response to correspondence on the molecular biology of head and
neck cancer. Nat Rev Cancer. 11:382. 2011.
|
|
5
|
Adeyi A and Olugbenga S: The challenges of
managing malignant head and neck tumors in a tropical tertiary
health center in Nigeria. Pan Afr Med J. 10(31)2011.PubMed/NCBI
|
|
6
|
Cramer JD, Burtness B, Le QT and Ferris
RL: The changing therapeutic landscape of head and neck cancer. Nat
Rev Clin Oncol. 16:669–683. 2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Alterio D, Marvaso G, Ferrari A, Volpe S,
Orecchia R and Jereczek-Fossa BA: Modern radiotherapy for head and
neck cancer. Semin Oncol. 46:233–245. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Owusu-Afriyie O, Owiredu WKBA,
Owusu-Danquah K, Komarck C, Foltin SK, Larsen-Reindorf R,
Acheampong E, Quayson SE, Prince MEP, McHugh JB, et al: Expression
of immunohistochemical markers in non-oropharyngeal head and neck
squamous cell carcinoma in Ghana. PLoS One.
13(e0202790)2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Barnes P, Yeboah F, Zhu J, Saahene RO,
Akakpo P and Ephrraim RK: Prognostic significance of epidermal
growth factor receptor (EGFR) in head and neck tumours at some
selected hospital In Ghana, 2019.
|
|
10
|
Barnes P, Yeboah FA, Zhu J, Saahene RO,
Obirikorang C, Adinortey MB, Amoani B, Kyei F, Akakpo P and Awuku
YA: Prognostic worth of epidermal growth factor receptor (EGFR) in
patients with head and neck tumors. J Cancer Epidemiol.
2020(5615303)2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Morgan EL, Chen Z and Van Waes C:
Regulation of NFκB signalling by ubiquitination: A potential
therapeutic target in head and neck squamous cell carcinoma?
Cancers (Basel). 12(2877)2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Taniguchi K and Karin M: NF-κB,
inflammation, immunity and cancer: Coming of age. Nat Rev Immunol.
18:309–324. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Perkins ND: The diverse and complex roles
of NF-κB subunits in cancer. Nat Rev Cancer. 12:121–132.
2012.PubMed/NCBI View
Article : Google Scholar
|
|
14
|
El-Rayes BF, Ali S, Ali IF, Philip PA,
Abbruzzese J and Sarkar FH: Potentiation of the effect of erlotinib
by genistein in pancreatic cancer: The role of Akt and nuclear
factor-kappaB. Cancer Res. 66:10553–10559. 2006.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Biswas DK, Shi Q, Baily S, Strickland I,
Ghosh S, Pardee AB and Iglehart JD: NF-kappa B activation in human
breast cancer specimens and its role in cell proliferation and
apoptosis. Proc Natl Acad Sci USA 10137-10142, 2004.
|
|
16
|
Kim HJ, Hawke N and Baldwin AS: NF-kappa B
and IKK as therapeutic targets in cancer. Cell Death Differ.
13:738–747. 2006.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Terzić J, Grivennikov S, Karin E and Karin
M: Inflammation and colon cancer. Gastroenterology.
138:2101–2114.e5. 2010.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Li CW, Xia W, Huo L, Lim SO, Wu Y, Hsu JL,
Chao CH, Yamaguchi H, Yang NK, Ding Q, et al:
Epithelial-mesenchymal transition induced by TNF-α requires
NF-κB-mediated transcriptional upregulation of Twist1. Cancer Res.
72:1290–1300. 2012.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Chou YC, Sheu JR, Chung CL, Chen CY, Lin
FL, Hsu MJ, Kuo YH and Hsiao G: Nuclear-targeted inhibition of
NF-kappaB on MMP-9 production by N-2-(4-bromophenyl) ethyl
caffeamide in human monocytic cells. Chem Biol Interact.
184:403–412. 2010.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Barnes P, Mensah A, Derkyi-Kwarteng L,
Adankwa E, Agbo E, Yahaya ES, Amoani B, Adjei G, Ka-Chungu SMA,
Akakpo PK, et al: Prognostic significance of nuclear factor kappa B
(p65) among breast cancer patients in cape coast teaching hospital.
Med Princ Pract. 33:1–11. 2024.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Adankwah E, Danquah K, Gyamfi D, Sampene
P, Ossei P and Asiamah E: Nuclear localisation of autophagic p62
and associated cytoplasmic Beclin-1 and Bcl-2 expressions in
adenomas and adenocarcinomas of the colorectal regions. J Carcinog
Mutagen. 9(2)2018.
|
|
22
|
Yang X, Cheng H, Chen J, Wang R, Saleh A,
Si H, Lee S, Guven-Maiorov E, Keskin O, Gursoy A, et al: Head and
neck cancers promote an inflammatory transcriptome through
coactivation of classic and alternative NF-κB pathways. Cancer
Immunol Res. 7:1760–1774. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Xia Y, Shen S and Verma IM: NF-κB, an
active player in human cancers. Cancer Immunol Res. 2:823–830.
2014.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Baba M, Takahashi M, Yamashiro K, Yokoo H,
Fukai M, Sato M, Hosoda M, Kamiyama T, Taketomi A and Yamashita H:
Strong cytoplasmic expression of NF-κB/p65 correlates with a good
prognosis in patients with triple-negative breast cancer. Surgery
Today. 46:843–851. 2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Al-Mutairi MS and Habashy HO: Nuclear
factor-κB clinical significance in breast cancer: An
immunohistochemical study. Med Princ Pract. 32:33–39.
2023.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Yan M, Xu Q, Zhang P, Zhou XJ, Zhang ZY
and Chen WT: Correlation of NF-kappaB signal pathway with tumor
metastasis of human head and neck squamous cell carcinoma. BMC
Cancer. 10(437)2010.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Pasquali D, Giacomelli L, Pedicillo MC,
Conzo G, Gentile G, De Stefano IS, Angelillis F, Santoro A, Miele
F, Digitale Selvaggio L, et al: Tumor inflammatory microenvironment
of the thyroid cancer: Relationship between regulatory T-Cell
imbalance, and p-NFΚB (p65) Expression-A preliminary study. J Clin
Med. 12(6817)2023.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Roved J, Westerdahl H and Hasselquist D:
Sex differences in immune responses: Hormonal effects, antagonistic
selection, and evolutionary consequences. Horm Behav. 88:95–105.
2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Zhou XL, Fan W, Yang G and Yu MX: The
clinical significance of PR, ER, NF-κB, and TNF-α in breast cancer.
Dis Markers. 2014(494581)2014.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Pyo JS and Kim EK: Clinicopathological
significance and prognostic implication of nuclear factor-κB
activation in colorectal cancer. Pathol Res Pract.
215(152469)2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Songkiatisak PS, Rahman MT, Aqdas M and
Sung MH: NF-κB, a culprit of both inflamm-ageing and declining
immunity? Immun Ageing. 19(20)2022.PubMed/NCBI View Article : Google Scholar
|
